ArticleBiomedicines2024

Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical Context.

Zvonimir Petric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.